Learning Objectives: -Summarize the epidemiology and burden of EBV+ PTLD -Differentiate among current and emerging prognostic scoring systems for EBV+ PTLD in order to inform treatment decisions -Evaluate the latest clinical evidence of emerging treatment options for EBV+ PTLD, based on safety, efficacy, mechanism of action, treatment- and disease-specific factors to determine optimal treatment strategies for patients with EBV+ PTLD
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://learn.mlieducation.org/
- Start Date: 2024-09-25 05:00:00
- End Date: 2024-09-25 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: American Society for Transplantation and Cellular Therapy (ASTCT) - Amount: 0 - Is Kind Support: False Source: National Marrow Donor Program (NMDP) - Amount: 0 - Is Kind Support: False Source: Pierre Fabre - Amount: 54082.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine, Medical Oncology
Subscribe
Login
0 Comments
Oldest